title: Optimization of formulation variables for the development of long acting microsphere based depot injection of olanzapine.
abstract: This work was aimed to optimize the composition of microspheres of olanzapine to design long acting depot injection for the treatment of psychosis. Solvent evaporation method was used for the fabrication of microspheres. Different formulation variables for the solvent evaporation method, viz., effect of theoretical drug loading, type of surfactant and its concentration, temperature, volume of external phase and presence of salt in external aqueous phase, conditions and time of solvent evaporation and drying methodology were optimized. The microspheres were characterized for encapsulation efficiency, particle size, surface morphology, residual solvent content, drug release profile and drug release kinetics. The optimized formulation showed consistent drug release for upto 14 days time period.
authors.affiliation: Industrial Pharmacy Research Lab, Department of Pharmacy, Shri G.S. Institute of Technology and Science, Indore, India.
authors.forename: T
authors.initials: T
authors.lastname: Nahata
authors.forename: T R
authors.initials: TR
authors.lastname: Saini
mesh_terms: D001569:Benzodiazepines / Q000008:administration & dosage* / Q000737:chemistry; D002626:Chemistry, Pharmaceutical / Q000379:methods; D003692:Delayed-Action Preparations / Q000008:administration & dosage*; D004339:Drug Compounding / Q000379:methods; D016503:Drug Delivery Systems; D006863:Hydrogen-Ion Concentration; D007700:Kinetics; D008855:Microscopy, Electron, Scanning / Q000379:methods; D008863:Microspheres; D000077152:Olanzapine; D010316:Particle Size; D012492:Salts / Q000737:chemistry; D017367:Selective Serotonin Reuptake Inhibitors / Q000008:administration & dosage*; D012997:Solvents / Q000737:chemistry; D013501:Surface-Active Agents / Q000737:chemistry; D013696:Temperature
chemical_list: D001569:Benzodiazepines; D003692:Delayed-Action Preparations; D000077152:Olanzapine; D012492:Salts; D017367:Selective Serotonin Reuptake Inhibitors; D012997:Solvents; D013501:Surface-Active Agents